Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

13.55
+0.08000.59%
Post-market: 13.550.00000.00%16:34 EDT
Volume:1.22M
Turnover:16.52M
Market Cap:1.50B
PE:-8.85
High:13.84
Open:13.44
Low:13.32
Close:13.47
52wk High:17.49
52wk Low:3.11
Shares:110.54M
Float Shares:65.45M
Volume Ratio:0.95
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5305
EPS(LYR):-1.5305
ROE:-61.59%
ROA:-36.41%
PB:4.91
PE(LYR):-8.85

Loading ...

Amylyx Pharmaceuticals Price Target Maintained With a $34.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 25

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Economic Data Releases

MT Newswires Live
·
Mar 24

Amylyx completes enrollment in Phase 3 Lucidity trial of avexitide

TIPRANKS
·
Mar 24

Amylyx completes enrollment of 78 participants in Phase 3 LUCIDITY trial of avexitide in post-bariatric hypoglycemia

Reuters
·
Mar 24

Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 Lucidity Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

THOMSON REUTERS
·
Mar 24

Amylyx Pharmaceuticals Inc - Topline Data Readout for Lucidity Trial Anticipated in Q3 2026

THOMSON REUTERS
·
Mar 24

Amylyx Pharmaceuticals Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 19

Stock Track | Amylyx Pharmaceuticals Soars 5.24% Intraday After H.C. Wainwright Raises Price Target to $34

Stock Track
·
Mar 05

Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 05

Amylyx price target raised to $34 from $28 at H.C. Wainwright

TIPRANKS
·
Mar 04

Amylyx Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $34 From $28

THOMSON REUTERS
·
Mar 04

Stock Track | Amylyx Pharmaceuticals Plummets 5.52% Intraday Following Shelf Offering Announcement

Stock Track
·
Mar 03

Amylyx Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 03

Amylyx files automatic mixed securities shelf

TIPRANKS
·
Mar 03

Amylyx Pharmaceuticals Inc - Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Mar 03

Amylyx reports Q4 EPS (30c), consensus (34c)

TIPRANKS
·
Mar 03

Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q4 Net Loss $0.30 a Share, vs. FactSet Est of $0.29 Loss

MT Newswires Live
·
Mar 03

Amylyx Pharmaceuticals Q4 net loss beats estimates

Reuters
·
Mar 03

Amylyx posts FY 2025 net loss of USD 144.7 million, down 52.0%

Reuters
·
Mar 03

Amylyx Pharma Q4 EPS $(0.30) Beats $(0.36) Estimate

Benzinga
·
Mar 03